Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.

Kawamura Y, Nakaoka H, Nakayama A, Okada Y, Yamamoto K, Higashino T, Sakiyama M, Shimizu T, Ooyama H, Ooyama K, Nagase M, Hidaka Y, Shirahama Y, Hosomichi K, Nishida Y, Shimoshikiryo I, Hishida A, Katsuura-Kamano S, Shimizu S, Kawaguchi M, Uemura H, Ibusuki R, Hara M, Naito M, Takao M, Nakajima M, Iwasawa S, Nakashima H, Ohnaka K, Nakamura T, Stiburkova B, Merriman TR, Nakatochi M, Ichihara S, Yokota M, Takada T, Saitoh T, Kamatani Y, Takahashi A, Arisawa K, Takezaki T, Tanaka K, Wakai K, Kubo M, Hosoya T, Ichida K, Inoue I, Shinomiya N, Matsuo H.

Ann Rheum Dis. 2019 Oct;78(10):1430-1437. doi: 10.1136/annrheumdis-2019-215521. Epub 2019 Jul 8.

2.

Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.

Sakiyama MJ, Espinoza I, Reddy A, de Carlo F, Kumar A, Levenson AS, Bae S, Zhou X, Claudio PP, Lewin J, Manucha V, Pound CR, Vijayakumar S, Gomez CR.

Exp Mol Pathol. 2019 Jun;108:173-182. doi: 10.1016/j.yexmp.2019.04.010. Epub 2019 Apr 17.

PMID:
31004600
3.

Pediatric drug regulation: International perspectives.

Baum VC, Bax R, Heon D, Yang Z, Sakiyama M.

Paediatr Anaesth. 2019 Jun;29(6):572-582. doi: 10.1111/pan.13638. Epub 2019 Apr 14.

PMID:
30924233
4.

Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel.

Izawa Y, Kashii-Magaribuchi K, Yoshida K, Nosaka M, Tsuji N, Yamamoto A, Kuroyanagi K, Tono K, Tanihata M, Imanishi M, Onishi M, Sakiyama M, Inoue S, Takahashi R.

Acta Histochem Cytochem. 2018 Dec 20;51(6):173-183. doi: 10.1267/ahc.18041. Epub 2018 Dec 15.

5.

Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression.

Takada T, Yamamoto T, Matsuo H, Tan JK, Ooyama K, Sakiyama M, Miyata H, Yamanashi Y, Toyoda Y, Higashino T, Nakayama A, Nakashima A, Shinomiya N, Ichida K, Ooyama H, Fujimori S, Suzuki H.

Sci Rep. 2018 Jul 24;8(1):11147. doi: 10.1038/s41598-018-29208-w.

6.

Long-lived luminescence of colloidal silicon quantum dots for time-gated fluorescence imaging in the second near infrared window in biological tissue.

Sakiyama M, Sugimoto H, Fujii M.

Nanoscale. 2018 Aug 7;10(29):13902-13907. doi: 10.1039/c8nr03571g. Epub 2018 Jul 12.

PMID:
29999078
7.

Common variant of BCAS3 is associated with gout risk in Japanese population: the first replication study after gout GWAS in Han Chinese.

Sakiyama M, Matsuo H, Nakaoka H, Kawamura Y, Kawaguchi M, Higashino T, Nakayama A, Akashi A, Ueyama J, Kondo T, Wakai K, Sakurai Y, Yamamoto K, Ooyama H, Shinomiya N.

BMC Med Genet. 2018 Jun 7;19(1):96. doi: 10.1186/s12881-018-0583-z.

8.

Visualizing a core-shell structure of heavily doped silicon quantum dots by electron microscopy using an atomically thin support film.

Sugimoto H, Yamamura M, Sakiyama M, Fujii M.

Nanoscale. 2018 Apr 26;10(16):7357-7362. doi: 10.1039/c7nr09474d.

PMID:
29637958
9.

Proposal for the development of biologics in pediatric rheumatology.

Mori M, Nakagawa M, Tsuchida N, Kawada K, Sato J, Sakiyama M, Hirano S, Sato K, Nakamura H.

Pediatr Int. 2018 Feb;60(2):108-114. doi: 10.1111/ped.13495. Review.

PMID:
29288517
10.

Multiple common and rare variants of ABCG2 cause gout.

Higashino T, Takada T, Nakaoka H, Toyoda Y, Stiburkova B, Miyata H, Ikebuchi Y, Nakashima H, Shimizu S, Kawaguchi M, Sakiyama M, Nakayama A, Akashi A, Tanahashi Y, Kawamura Y, Nakamura T, Wakai K, Okada R, Yamamoto K, Hosomichi K, Hosoya T, Ichida K, Ooyama H, Suzuki H, Inoue I, Merriman TR, Shinomiya N, Matsuo H.

RMD Open. 2017 Aug 29;3(2):e000464. doi: 10.1136/rmdopen-2017-000464. eCollection 2017.

11.

A common variant of MAF/c-MAF, transcriptional factor gene in the kidney, is associated with gout susceptibility.

Higashino T, Matsuo H, Okada Y, Nakashima H, Shimizu S, Sakiyama M, Tadokoro S, Nakayama A, Kawaguchi M, Komatsu M, Hishida A, Nakatochi M, Ooyama H, Imaki J, Shinomiya N.

Hum Cell. 2018 Jan;31(1):10-13. doi: 10.1007/s13577-017-0186-6. Epub 2017 Oct 28.

PMID:
29080939
12.

Pyoderma gangrenosum and underlying diseases in Japanese patients: A regional long-term study.

Inoue S, Furuta JI, Fujisawa Y, Onizawa S, Ito S, Sakiyama M, Kobayashi K, Kanou T, Iijima S, Ohi T, Okubo C, Moriyama Y, Okiyama N, Fujimoto M.

J Dermatol. 2017 Nov;44(11):1281-1284. doi: 10.1111/1346-8138.13937. Epub 2017 Jun 21.

PMID:
28635156
13.

Independent effects of ADH1B and ALDH2 common dysfunctional variants on gout risk.

Sakiyama M, Matsuo H, Akashi A, Shimizu S, Higashino T, Kawaguchi M, Nakayama A, Naito M, Kawai S, Nakashima H, Sakurai Y, Ichida K, Shimizu T, Ooyama H, Shinomiya N.

Sci Rep. 2017 May 31;7(1):2500. doi: 10.1038/s41598-017-02528-z.

14.

Expression of a human NPT1/SLC17A1 missense variant which increases urate export.

Sakiyama M, Matsuo H, Nagamori S, Ling W, Kawamura Y, Nakayama A, Higashino T, Chiba T, Ichida K, Kanai Y, Shinomiya N.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):536-542.

PMID:
27906618
15.

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.

Nakayama A, Nakaoka H, Yamamoto K, Sakiyama M, Shaukat A, Toyoda Y, Okada Y, Kamatani Y, Nakamura T, Takada T, Inoue K, Yasujima T, Yuasa H, Shirahama Y, Nakashima H, Shimizu S, Higashino T, Kawamura Y, Ogata H, Kawaguchi M, Ohkawa Y, Danjoh I, Tokumasu A, Ooyama K, Ito T, Kondo T, Wakai K, Stiburkova B, Pavelka K, Stamp LK, Dalbeth N; Eurogout Consortium, Sakurai Y, Suzuki H, Hosoyamada M, Fujimori S, Yokoo T, Hosoya T, Inoue I, Takahashi A, Kubo M, Ooyama H, Shimizu T, Ichida K, Shinomiya N, Merriman TR, Matsuo H; Eurogout Consortium.

Ann Rheum Dis. 2017 May;76(5):869-877. doi: 10.1136/annrheumdis-2016-209632. Epub 2016 Nov 29.

16.

Common variant of PDZ domain containing 1 (PDZK1) gene is associated with gout susceptibility: A replication study and meta-analysis in Japanese population.

Higashino T, Matsuo H, Sakiyama M, Nakayama A, Nakamura T, Takada T, Ogata H, Kawamura Y, Kawaguchi M, Naito M, Kawai S, Takada Y, Ooyama H, Suzuki H, Shinomiya N.

Drug Metab Pharmacokinet. 2016 Dec;31(6):464-466. doi: 10.1016/j.dmpk.2016.07.004. Epub 2016 Jul 30.

17.

Self-Assembled Nanogels of Cholesterol-Bearing Hydroxypropyl Cellulose: A Thermoresponsive Building Block for Nanogel Tectonic Materials.

Tahara Y, Sakiyama M, Takeda S, Nishimura T, Mukai SA, Sawada SI, Sasaki Y, Akiyoshi K.

Langmuir. 2016 Nov 29;32(47):12283-12289. Epub 2016 Sep 23.

PMID:
27662236
18.

Meta-analysis confirms an association between gout and a common variant of LRRC16A locus.

Ogata H, Matsuo H, Sakiyama M, Higashino T, Kawaguchi M, Nakayama A, Naito M, Ooyama H, Ichida K, Shinomiya N.

Mod Rheumatol. 2017 May;27(3):553-555. doi: 10.1080/14397595.2016.1218413. Epub 2016 Sep 1. No abstract available.

PMID:
27585540
19.

Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2.

Matsuo H, Tsunoda T, Ooyama K, Sakiyama M, Sogo T, Takada T, Nakashima A, Nakayama A, Kawaguchi M, Higashino T, Wakai K, Ooyama H, Hokari R, Suzuki H, Ichida K, Inui A, Fujimori S, Shinomiya N.

Sci Rep. 2016 Aug 30;6:31003. doi: 10.1038/srep31003.

20.

Tuberculous cellulitis: diseases behind cellulitislike erythema.

Sakiyama M, Maeshima H, Chishiki M, Horinosono H, Kawakubo Y.

Cutis. 2016 Jul;98(1):E14-8.

PMID:
27529716
21.

Lack of association between alopecia areata and HLA class I and II in a southeastern Brazilian population.

Barbosa ÂM, Prestes-Carneiro LE, Sobral AR, Sakiyama MJ, Lemos BC, Abreu MA, Martos LL, Moliterno RA.

An Bras Dermatol. 2016 May-Jun;91(3):284-9. doi: 10.1590/abd1806-4841.20164250.

22.

Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells.

Espinoza I, Sakiyama MJ, Ma T, Fair L, Zhou X, Hassan M, Zabaleta J, Gomez CR.

Front Oncol. 2016 Jun 15;6:144. doi: 10.3389/fonc.2016.00144. eCollection 2016.

23.

The Good, the Bad, and the Ugly: Professional Perceptions of Jury Decision-making Research Practices.

Lieberman JD, Krauss DA, Heen M, Sakiyama M.

Behav Sci Law. 2016 Jul;34(4):495-514. doi: 10.1002/bsl.2246. Epub 2016 May 19. No abstract available.

PMID:
27193481
24.

Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus.

Sakiyama M, Matsuo H, Nakaoka H, Yamamoto K, Nakayama A, Nakamura T, Kawai S, Okada R, Ooyama H, Shimizu T, Shinomiya N.

Sci Rep. 2016 May 16;6:25360. doi: 10.1038/srep25360.

25.

The effects of URAT1/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression.

Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakamura T, Nakayama A, Higashino T, Naito M, Suma S, Hishida A, Satoh T, Sakurai Y, Takada T, Ichida K, Ooyama H, Shimizu T, Shinomiya N.

Sci Rep. 2016 Jan 29;6:20148. doi: 10.1038/srep20148.

26.

NRF2 Is a Key Target for Prevention of Noise-Induced Hearing Loss by Reducing Oxidative Damage of Cochlea.

Honkura Y, Matsuo H, Murakami S, Sakiyama M, Mizutari K, Shiotani A, Yamamoto M, Morita I, Shinomiya N, Kawase T, Katori Y, Motohashi H.

Sci Rep. 2016 Jan 18;6:19329. doi: 10.1038/srep19329.

27.

Effects of oxygen on the antigenic landscape of prostate cancer cells.

Ma T, Schreiber CA, Knutson GJ, Khattouti AE, Sakiyama MJ, Hassan M, Charlesworth MC, Madden BJ, Zhou X, Vuk-Pavlović S, Gomez CR.

BMC Res Notes. 2015 Nov 18;8:687. doi: 10.1186/s13104-015-1633-7.

28.

ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout.

Matsuo H, Tomiyama H, Satake W, Chiba T, Onoue H, Kawamura Y, Nakayama A, Shimizu S, Sakiyama M, Funayama M, Nishioka K, Shimizu T, Kaida K, Kamakura K, Toda T, Hattori N, Shinomiya N.

Ann Clin Transl Neurol. 2015 Mar;2(3):302-6. doi: 10.1002/acn3.167. Epub 2015 Jan 19.

29.

Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.

Matsuo H, Yamamoto K, Nakaoka H, Nakayama A, Sakiyama M, Chiba T, Takahashi A, Nakamura T, Nakashima H, Takada Y, Danjoh I, Shimizu S, Abe J, Kawamura Y, Terashige S, Ogata H, Tatsukawa S, Yin G, Okada R, Morita E, Naito M, Tokumasu A, Onoue H, Iwaya K, Ito T, Takada T, Inoue K, Kato Y, Nakamura Y, Sakurai Y, Suzuki H, Kanai Y, Hosoya T, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, Shinomiya N.

Ann Rheum Dis. 2016 Apr;75(4):652-9. doi: 10.1136/annrheumdis-2014-206191. Epub 2015 Feb 2.

30.

Common variant of PDZK1, adaptor protein gene of urate transporters, is not associated with gout.

Takada Y, Matsuo H, Nakayama A, Sakiyama M, Hishida A, Okada R, Sakurai Y, Shimizu T, Ichida K, Shinomiya N.

J Rheumatol. 2014 Nov;41(11):2330-1. doi: 10.3899/jrheum.140573. No abstract available.

PMID:
25362723
31.

Common variant of ALPK1 is not associated with gout: a replication study.

Chiba T, Matsuo H, Sakiyama M, Nakayama A, Shimizu S, Wakai K, Suma S, Nakashima H, Sakurai Y, Shimizu T, Ichida K, Shinomiya N.

Hum Cell. 2015 Jan;28(1):1-4. doi: 10.1007/s13577-014-0103-1. Epub 2014 Oct 19.

32.

NPT1/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout.

Chiba T, Matsuo H, Kawamura Y, Nagamori S, Nishiyama T, Wei L, Nakayama A, Nakamura T, Sakiyama M, Takada T, Taketani Y, Suma S, Naito M, Oda T, Kumagai H, Moriyama Y, Ichida K, Shimizu T, Kanai Y, Shinomiya N.

Arthritis Rheumatol. 2015 Jan;67(1):281-7. doi: 10.1002/art.38884.

33.

ABCG2 dysfunction increases the risk of renal overload hyperuricemia.

Matsuo H, Takada T, Nakayama A, Shimizu T, Sakiyama M, Shimizu S, Chiba T, Nakashima H, Nakamura T, Takada Y, Sakurai Y, Hosoya T, Shinomiya N, Ichida K.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):266-74. doi: 10.1080/15257770.2013.866679.

PMID:
24940678
34.

Identification of a hypouricemia patient with SLC2A9 R380W, a pathogenic mutation for renal hypouricemia type 2.

Chiba T, Matsuo H, Nagamori S, Nakayama A, Kawamura Y, Shimizu S, Sakiyama M, Hosoyamada M, Kawai S, Okada R, Hamajima N, Kanai Y, Shinomiya N.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):261-5. doi: 10.1080/15257770.2013.857781.

PMID:
24940677
35.

Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.

Nakayama A, Matsuo H, Nakaoka H, Nakamura T, Nakashima H, Takada Y, Oikawa Y, Takada T, Sakiyama M, Shimizu S, Kawamura Y, Chiba T, Abe J, Wakai K, Kawai S, Okada R, Tamura T, Shichijo Y, Akashi A, Suzuki H, Hosoya T, Sakurai Y, Ichida K, Shinomiya N.

Sci Rep. 2014 Jun 9;4:5227. doi: 10.1038/srep05227.

36.

Common variants of cGKII/PRKG2 are not associated with gout susceptibility.

Sakiyama M, Matsuo H, Chiba T, Nakayama A, Nakamura T, Shimizu S, Morita E, Fukuda N, Nakashima H, Sakurai Y, Ichida K, Shimizu T, Shinomiya N.

J Rheumatol. 2014 Jul;41(7):1395-7. doi: 10.3899/jrheum.131548. Epub 2014 Jun 1.

37.

Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.

Sakiyama M, Matsuo H, Takada Y, Nakamura T, Nakayama A, Takada T, Kitajiri S, Wakai K, Suzuki H, Shinomiya N.

Drug Metab Pharmacokinet. 2014;29(6):490-2. doi: 10.2133/dmpk.DMPK-14-SC-041. Epub 2014 May 27.

38.

ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.

Matsuo H, Nakayama A, Sakiyama M, Chiba T, Shimizu S, Kawamura Y, Nakashima H, Nakamura T, Takada Y, Oikawa Y, Takada T, Nakaoka H, Abe J, Inoue H, Wakai K, Kawai S, Guang Y, Nakagawa H, Ito T, Niwa K, Yamamoto K, Sakurai Y, Suzuki H, Hosoya T, Ichida K, Shimizu T, Shinomiya N.

Sci Rep. 2014 Jan 20;4:3755. doi: 10.1038/srep03755.

39.

Eruptive syringoma localized in intertriginous areas.

Sakiyama M, Maeda M, Fujimoto N, Satoh T.

J Dtsch Dermatol Ges. 2014 Jan;12(1):72-3. doi: 10.1111/ddg.12203. No abstract available.

PMID:
24393317
40.

Photolocalized varicella in an adult.

Sakiyama M, Maeshima H, Higashino T, Kawakubo Y.

Br J Dermatol. 2014 May;170(5):1195-6. doi: 10.1111/bjd.12814. No abstract available.

PMID:
24372142
41.

Common variants of a urate-associated gene LRP2 are not associated with gout susceptibility.

Nakayama A, Matsuo H, Shimizu T, Takada Y, Nakamura T, Shimizu S, Chiba T, Sakiyama M, Naito M, Morita E, Ichida K, Shinomiya N.

Rheumatol Int. 2014 Apr;34(4):473-6. doi: 10.1007/s00296-013-2924-8. Epub 2013 Dec 24.

42.

Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility.

Sakiyama M, Matsuo H, Shimizu S, Chiba T, Nakayama A, Takada Y, Nakamura T, Takada T, Morita E, Naito M, Wakai K, Inoue H, Tatsukawa S, Sato J, Shimono K, Makino T, Satoh T, Suzuki H, Kanai Y, Hamajima N, Sakurai Y, Ichida K, Shimizu T, Shinomiya N.

Hum Cell. 2014 Jan;27(1):1-4. doi: 10.1007/s13577-013-0081-8. Epub 2013 Dec 7.

43.

A common variant of organic anion transporter 4 (OAT4/SLC22A11) gene is associated with renal underexcretion type gout.

Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakayama A, Chiba T, Naito M, Takada T, Suzuki H, Hamajima N, Ichida K, Shimizu T, Shinomiya N.

Drug Metab Pharmacokinet. 2014;29(2):208-10. Epub 2013 Sep 10.

44.

Common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility.

Nakayama A, Matsuo H, Shimizu T, Ogata H, Takada Y, Nakashima H, Nakamura T, Shimizu S, Chiba T, Sakiyama M, Ushiyama C, Takada T, Inoue K, Kawai S, Hishida A, Wakai K, Hamajima N, Ichida K, Sakurai Y, Kato Y, Shimizu T, Shinomiya N.

Hum Cell. 2013 Dec;26(4):133-6. doi: 10.1007/s13577-013-0073-8. Epub 2013 Aug 29.

45.

Surface modification of mammalian cells with stimuli-responsive polymers.

Iwasaki Y, Sakiyama M, Fujii S, Yusa S.

Chem Commun (Camb). 2013 Sep 14;49(71):7824-6. doi: 10.1039/c3cc44072a.

PMID:
23884331
46.

Common dysfunctional variants in ABCG2 are a major cause of early-onset gout.

Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T, Kawamura Y, Takada Y, Yamamoto K, Inoue H, Oikawa Y, Naito M, Hishida A, Wakai K, Okada C, Shimizu S, Sakiyama M, Chiba T, Ogata H, Niwa K, Hosoyamada M, Mori A, Hamajima N, Suzuki H, Kanai Y, Sakurai Y, Hosoya T, Shimizu T, Shinomiya N.

Sci Rep. 2013;3:2014. doi: 10.1038/srep02014.

47.

Preventable frostbite due to cold pack.

Sakiyama M, Kawakubo Y.

Int Wound J. 2015 Jun;12(3):366. doi: 10.1111/iwj.12105. Epub 2013 May 28. No abstract available.

PMID:
23711291
48.

Bullous pyoderma gangrenosum: a case report and review of the published work.

Sakiyama M, Kobayashi T, Nagata Y, Fujimoto N, Satoh T, Tajima S.

J Dermatol. 2012 Dec;39(12):1010-5. doi: 10.1111/j.1346-8138.2012.01676.x. Epub 2012 Sep 14. Review.

PMID:
22974277
49.

[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].

Teranishi H, Sakiyama M, Nagatoshi Y, Nomura Y, Inagaki J, Yanai F, Okamura J.

Rinsho Ketsueki. 2011 May;52(5):287-92. Japanese.

PMID:
21646775
50.

Rituximab-containing therapy for chronic lymphocytic leukaemia.

Tanimoto T, Sakiyama M, Hori A, Yagasaki F, Kami M.

Lancet. 2011 Jan 15;377(9761):205; author reply 206. doi: 10.1016/S0140-6736(11)60041-X. No abstract available.

PMID:
21237394

Supplemental Content

Loading ...
Support Center